Soluble Expression and Purification of Receptor Activator of Nuclear Factor-Kappa B Ligand Using Escherichia coli
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Receptor activator of nuclear factor-kappa B ligand (RANKL) is a critical factor in osteoclastogenesis. It makes osteoclasts differentiate and multinucleate in bone remodeling. In the present study, RANKL was expressed as a soluble maltose binding protein (MBP)-fusion protein using the Escherichia coli maltose binding domain tag system (pMAL) expression vector system. The host cell E. coli DH5α was cultured and induced by isopropyl β-D-1- thiogalactopyranoside for rRANKL expression. Cells were disrupted by sonication to collect soluble MBP-fused rRANKL. The MBP-fusion rRANKL was purified with MBP Trap affinity chromatography and treated with Tobacco Etch Virus nuclear inclusion endopeptidase (TEV protease) to remove the MBP fusion protein. Dialysis was then carried out to remove binding maltose from the cleaved rRANKL solution. The cleaved rRANKL was purified with a second MBP Trap affinity chromatography to separate unsevered MBP-fusion rRANKL and cleaved MBP fusion protein. The purified rRANKL was shown to have biological activity by performing in vitro cell tests. In conclusion, biologically active rRANKL was successfully purified by a simple two-step chromatography purification process with one column.
Abstract
Receptor activator of nuclear factor-kappa B ligand (RANKL) is a critical factor in osteoclastogenesis. It makes osteoclasts differentiate and multinucleate in bone remodeling. In the present study, RANKL was expressed as a soluble maltose binding protein (MBP)-fusion protein using the Escherichia coli maltose binding domain tag system (pMAL) expression vector system. The host cell E. coli DH5α was cultured and induced by isopropyl β-D-1- thiogalactopyranoside for rRANKL expression. Cells were disrupted by sonication to collect soluble MBP-fused rRANKL. The MBP-fusion rRANKL was purified with MBP Trap affinity chromatography and treated with Tobacco Etch Virus nuclear inclusion endopeptidase (TEV protease) to remove the MBP fusion protein. Dialysis was then carried out to remove binding maltose from the cleaved rRANKL solution. The cleaved rRANKL was purified with a second MBP Trap affinity chromatography to separate unsevered MBP-fusion rRANKL and cleaved MBP fusion protein. The purified rRANKL was shown to have biological activity by performing in vitro cell tests. In conclusion, biologically active rRANKL was successfully purified by a simple two-step chromatography purification process with one column.
참고문헌 (16)
- Anderson DM, "A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function", Nature, 390, pp.175~179 (1997)
- Boyce BF, "Functions of RANKL", RANK, Arch. Biochem. Biophys, pp.2008, 473[DOI]
- Fata JE, "The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development", Cell, 103, pp.41~50 (2000)
- Gallagher JC, "Diagnosis, prophylaxis, and treatment of osteoporosis", Am. J. Med, 90, pp.646~650 (1994)
- Grigoriades AE, "c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling", Science, 266, pp.443~448 (1994)
- Ilich JZ, "Nutrition in bone health revisited: a story beyond calcium", J. Am. Coll. Nutr, 19, pp.715~737 (2000)
- Jeong TH, "Soluble expression and partial purification of recombinant human erythropoietin from E. coli", Protein Expr. Purif, 95, pp.211~218 (2014)
- Kanamaru F, "Expression of membrane-bound and soluble receptor activator of NF-kappa B ligand (RANKL) in human T cells", Immun. Lett, 94, pp.239~246 (2004)
- Kim NS, "Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells", Mol. Cell. Biol, 26, pp.1002~1013 (2006)
- Kong YY, "OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis", Nature, 397, pp.315~323 (1999)
- O’Brien CA, "Osteocyte control of osteoclastogenesis", Bone, 54, pp.258~263 (2012)
- Smith DM, "Genetic factors in determining bone mass", J. Clin. Invest, 52, pp.2800~2808 (1973)
- Wardlaw G., "The effects of diet and life-style on bone mass in women", J. Am. Diet. Assoc, 88, pp.17~25 (1988)
- Willard D, "Expression, purification, and characterization of the human receptor activator of NF-KB ligand (RANKL) extracellular domain", Protein Expr. Purif, 20, pp.48~57 (2000)
- Wong BR, "TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells", J. Biol. Chem, 272, pp.25190~25194 (1997)
- Xiong J, "Osteocyte RANKL: new insights into the control of bone remodeling", J. Bone Miner. Res, 27, pp.499~505 (2012)